Lancet Infectious Diseases Explores ART in Low-, Middle-Income Countries
October 9, 2009
"As a result of the scale-up of antiretroviral treatment (ART) programmes and substantial financial support worldwide, an increasing number of HIV-infected individuals in low-income and middle-income countries (LIMCs) now have access to ART," write the authors of a Lancet Infectious Diseases review article that explores the current issues faced by those attempting to manage the epidemic in low- and middle-income countries. The review includes information about when to start treatment as well as first- and second-line regimens (Bartlett/Shao, 10/2009).
Pharmaceutical Firms Agree to Continue Support for Canadian Program That Supplies Generic Drugs to Rwanda
Recent UN Progress Report on Universal Access Illustrates Need for Greater Financial and Political Commitment to AIDS on the Part of the G8 and Other Donors
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.